IL2 and neoplasm: Furthermore, the tumor microenvironment was completely reshaped toward anti-tumor inflammatory cells, as illustrated by changes in the CD8 to CD4 ratio and IFNγ-producing CD8+ T cells to T-regs ratio in the huCC49-IL-2-treated tumors and lymphoid organs (Figure 6G).